Senior Computational Biologist (Remote)
Output BiosciencesFull Time
Expert & Leadership (9+ years)
Key technologies and capabilities for this role
Common questions about this position
The expected salary range is applicable if the role is performed from California and may vary for other locations such as Colorado, Illinois, or New York. Actual salary may vary based on qualifications and experience.
This information is not specified in the job description. It mentions salary variations by location and notes about remote roles in unincorporated Los Angeles, but no explicit location type or remote policy is stated.
The position requires experience with scientific programming, relational data systems, algorithms development, and statistical modeling. Preferred skills include computational skills using Python, R, and/or Bioconductor, along with experience in cancer genomics and next-generation sequencing data.
Tempus emphasizes working in interdisciplinary groups of scientists, engineers, and product developers to translate research into clinically actionable insights. The role involves collaboration with scientists and clinicians in a self-driven team environment focused on precision medicine.
Top candidates have a Ph.D. in Bioinformatics, Computational Biology, or Genomics or 2+ years of relevant experience, plus experience deploying bioinformatics code in a clinical setting, cancer genomics, NGS data, workflow languages like CWL/WDL, cloud systems, and algorithm development.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.